These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18485264)

  • 1. Cannabis use and genetic predisposition for schizophrenia: a case-control study.
    Veling W; Mackenbach JP; van Os J; Hoek HW
    Psychol Med; 2008 Sep; 38(9):1251-6. PubMed ID: 18485264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
    Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
    Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alarming admission rates for schizophrenia in migrants from Surinam, the Netherlands Antilles and Morocco].
    Selten JP; Sijben AE
    Ned Tijdschr Geneeskd; 1994 Feb; 138(7):345-50. PubMed ID: 8121523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parental age and risk of schizophrenia: a case-control study.
    Byrne M; Agerbo E; Ewald H; Eaton WW; Mortensen PB
    Arch Gen Psychiatry; 2003 Jul; 60(7):673-8. PubMed ID: 12860771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999.
    Boydell J; van Os J; Caspi A; Kennedy N; Giouroukou E; Fearon P; Farrell M; Murray RM
    Psychol Med; 2006 Oct; 36(10):1441-6. PubMed ID: 16854250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment.
    Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
    J Subst Abuse Treat; 2007 Mar; 32(2):113-9. PubMed ID: 17306720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between ABCB1 C3435T polymorphism and increased risk of cannabis dependence.
    Benyamina A; Bonhomme-Faivre L; Picard V; Sabbagh A; Richard D; Blecha L; Rahioui H; Karila L; Lukasiewicz M; Farinotti R; Picard V; Marill C; Reynaud M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1270-4. PubMed ID: 19625010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults.
    McGrath J; Welham J; Scott J; Varghese D; Degenhardt L; Hayatbakhsh MR; Alati R; Williams GM; Bor W; Najman JM
    Arch Gen Psychiatry; 2010 May; 67(5):440-7. PubMed ID: 20194820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The environment and schizophrenia: the role of cannabis use.
    Henquet C; Murray R; Linszen D; van Os J
    Schizophr Bull; 2005 Jul; 31(3):608-12. PubMed ID: 15976013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
    Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
    Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia and cannabis use.
    Kumra S
    Minn Med; 2007 Jan; 90(1):36-8. PubMed ID: 17305103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychiatric admissions in Amsterdam according to ethnic background and diagnosis].
    Dekker J; Peen J; Heijnen H; Kwakman H; Sanders H
    Ned Tijdschr Geneeskd; 1996 Feb; 140(7):368-71. PubMed ID: 8628423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls.
    Dekker N; Smeerdijk AM; Wiers RW; Duits JH; van Gelder G; Houben K; Schippers G; Linszen DH; de Haan L
    Psychol Med; 2010 Aug; 40(8):1325-36. PubMed ID: 19917142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs.
    Genetic Risk and Outcome in Psychosis (GROUP) Investigators
    Arch Gen Psychiatry; 2011 Feb; 68(2):138-47. PubMed ID: 20921112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination and the incidence of psychotic disorders among ethnic minorities in The Netherlands.
    Veling W; Selten JP; Susser E; Laan W; Mackenbach JP; Hoek HW
    Int J Epidemiol; 2007 Aug; 36(4):761-8. PubMed ID: 17517810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth pattern and risk of schizophrenia.
    Haukka J; Suvisaari J; Häkkinen L; Lönnqvist J
    Psychol Med; 2008 Jan; 38(1):63-70. PubMed ID: 17506926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic carrier screening for hemoglobinopathies in the Netherlands is not opportune].
    Schulpen TW; van der Lee JH; van der Most van Spijk MW; Beemer FA
    Ned Tijdschr Geneeskd; 1998 May; 142(18):1019-22. PubMed ID: 9623203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting models of genetic co-morbidity for cannabis and other illicit drugs in adult Australian twins.
    Agrawal A; Lynskey MT; Bucholz KK; Martin NG; Madden PA; Heath AC
    Psychol Med; 2007 Jan; 37(1):49-60. PubMed ID: 17076916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alarming admission rates for schizophrenia in migrants from Surinam, the Netherlands Antilles and Morocco].
    van Harten PN; Egyedi MS; van de Hel EM; Matroos GE; Rambharos PR
    Ned Tijdschr Geneeskd; 1994 Dec; 138(53):2677-8. PubMed ID: 7830821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.